Open House Biologics Discount Agreements 2024-10 - Pertuzumab / Trastuzumab (Drug Combination)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 97554873

  Document Type - Tender Notices

Description - Description: The health insurance companies involved aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 of the Social Security Code (SGB V) for the active ingredient combination pertuzumab/trastuzumab. The contract is concluded as part of the open house biologics procedure of the health insurance companies involved: Individual negotiations on the contents of the contract are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners exclusivity. The contract term is a maximum of 24 months starting on January 1, 2025. The contract ends on December 31,

Gt Ref Id - 97554873

Deadline - Dec 31, 2026